RxDoctor Payments Data

Jan Altiser

Psychiatric/Mental Health · Trenton, MONPI 1336478601

Payments from drug & device makers

$3,931in general payments, 2019–2025

Across 217 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$636
  • Otsuka America Pharmaceutical, Inc.$633
  • AbbVie$629
  • Vanda Pharmaceuticals Inc.$390
  • Teva Pharmaceuticals USA, Inc.$307
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$303
  • plus $1K from 9 others

What the payments were for

  • Food & beverage$3,931100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,931 in reported general payments places this provider in the 80th percentile of 565 psychiatric/mental health providers in Missouri.

See all psychiatric/mental health providers in Missouri

Medicare billing

Part B allowed, 2024
$11,044
Medicare patients
41
Services billed
152

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl154$209,349
Abilify AsimtufiiAripiprazole11$64,160
AristadaAripiprazole Lauroxil15$50,798
TrintellixVortioxetine Hydrobromide27$12,872
Ziprasidone Hcl100$11,968
Paliperidone ErPaliperidone17$5,262
Chlorpromazine Hcl50$4,955
Aripiprazole77$2,466
Atomoxetine Hcl17$1,951
Benztropine Mesylate115$1,628
Lurasidone Hcl26$1,602
Oxcarbazepine52$1,566
Clozapine26$1,555
Quetiapine Fumarate144$1,325
Bupropion XlBupropion Hcl74$1,220

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$629$209,349154 claims
Otsuka America Pharmaceutical, Inc.Abilify Asimtufii$633$64,16011 claims
Alkermes, Inc.Aristada$197$50,79815 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$25$12,87227 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 565 psychiatric/mental health providers in Missouri.

Other psychiatric/mental health in Trenton

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →